MENU
PASG
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Passage Bio (PASG) Earnings Date & Reports
Passage Bio Inc is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases... Show more
A.I. Advisor
published Earnings
PASG is expected to report earnings to fall 1.76% to -278 cents per share on July 30
Q2'26
Est.
$-2.79
Q1'26
Missed
by $0.91
Q4'25
Missed
by $3.91
Q3'25
Missed
by $2.24
Q2'25
Missed
by $2.76
The last earnings report on May 19 showed earnings per share of -283 cents, missing the estimate of -192 cents. With 53.91K shares outstanding, the current market capitalization sits at 18.16M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
a genetic medicines company, which focuses on developing transformative therapies for rare, monogenic central nervous system disorders with limited or no approved treatment options
Industry Biotechnology
Profile
Details
Industry
N/A
Address
2005 Market Street
Phone
+1 267 866-0311
Employees
24
Web
https://www.passagebio.com